Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
25.18
+0.49 (1.98%)
At close: May 1, 2026, 4:00 PM EDT
25.30
+0.12 (0.48%)
After-hours: May 1, 2026, 6:41 PM EDT
Alumis Market Cap
Alumis has a market cap or net worth of $3.2 billion as of May 1, 2026. Its market cap has increased by 1,061.11% in one year.
Market Cap
3.20B
Enterprise Value
2.93B
1-Year Change
1,061.11%
Ranking
Category
Stock Price
$25.18
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.20B, an increase of 255.12%. That is a compound annual growth rate of 99.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.20B | 214.35% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 3.51B |
| Viking Therapeutics | 3.48B |
| Edgewise Therapeutics | 3.29B |
| NewAmsterdam Pharma Company | 3.27B |
| Kailera Therapeutics | 3.26B |
| Arcus Biosciences | 3.23B |
| Oruka Therapeutics | 3.14B |
| Erasca | 3.12B |